Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Cord Selection for Haplo-Cord Transplantation
NCT01810588Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2012
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in hematologic malignancy, sponsored by Weill Cornell Medicine. Started Oct 2012; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT01810588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810588.